Will Pfizer (PFE) beat quarterly earnings?: how this market works

What you need to know

This market asks whether Pfizer will earn more profit per share than analysts currently expect when it reports its next quarterly results. Specifically, the target is $0.68 in non-GAAP EPS, which is a company's earnings per share with certain one-time costs stripped out. A Yes means Pfizer clears that bar. A No means it lands exactly at $0.68 or below it. When Pfizer releases its earnings on or around August 4, 2026, the market checks the non-GAAP EPS figure in the official report. If that number is $0.69 or higher, it resolves Yes. At $0.68 or lower, it resolves No. If Pfizer delays its report by more than 45 days past August 4, it automatically resolves No. The first published figure is what counts, not any later corrections, unless there was an obvious clerical mistake. No relevant recent news was provided for this market. The kind of developments worth watching would include Pfizer updating its financial guidance, news about its key drug sales, cost-cutting announcements, or any regulatory decisions affecting its pipeline before the August 2026 report date. At 90%, the market is strongly leaning toward Yes, which reflects a well-known pattern: companies like Pfizer frequently clear analyst estimates because analysts tend to set targets conservatively. The main remaining uncertainty is not about two equal sides, it is simply whether something unexpected derails that pattern, such as a surprise revenue shortfall, a pipeline setback, or a broader economic shock between now and August 2026. That gap is real but historically narrow for large pharmaceutical companies.

The odds right now

• Will Pfizer (PFE) beat quarterly earnings?86%

Price history

How this resolves

Resolves August 4, 2026

As of market creation, Pfizer is estimated to release earnings on August 4, 2026. The Street consensus estimate for Pfizer’s non-GAAP EPS for the relevant quarter is $0.68 as of market creation. Read the full resolution rules on the live market page.

Related

Same markets. A fraction of the fee.

These apps all route to the same exchange order book. The difference is what each one adds on top of the exchange's own fee.

Published rates, checked July 2026. MetaMask charges a flat 4 percent per prediction trade. Jupiter adds a fee equal to the exchange's own taker fee at fill time, roughly 2 to 4 percent at typical odds. Where a market carries an exchange settlement fee, it applies everywhere, whichever app you use. Paridesk adds nothing on maker orders.

Trade this market on Paridesk: non-custodial, 0.5% fee.